Can You Get COVID-19 Again? Replay our May 22 HDLive!

Follow Our Live Coverage of COVID-19 Developments

A Lozenge to Help Smokers Quit

It's available without doctor's prescription

Please note: This article was published more than one year ago. The facts and conclusions presented may have since changed and may no longer be accurate. And "More information" links may no longer work. Questions about personal health should always be referred to a physician or other health care professional.

FRIDAY, Nov. 1, 2002 (HealthDayNews) -- An over-the-counter nicotine lozenge for smokers trying to kick the habit has been approved by the U.S. Food and Drug Administration.

GlaxoSmithKline's Commit is the first nicotine lozenge that doesn't require a doctor's prescription. Also the first of its kind to win FDA approval, it's available in two strengths and includes a method to determine a person's addiction to nicotine, the company says.

The "Time to First Cigarette" tool, for example, dictates that a nicotine-deprived person who wakes up requiring a cigarette within 30 minutes of awakening should take the 4 milligram strength lozenge. Those who can wait at least 30 minutes before they succumb to their craving are directed to use the 2 milligram strength.

The Commit lozenge helps relieve craving and withdrawal symptoms by providing a temporary alternate source of nicotine, without the harmful tars and carbon monoxide found in smoke. The person uses fewer and fewer lozenges during the 12-week program until he is able to stop the product entirely.

The 72-pack lozenges will be available next month for a suggested retail price of $39.95, GlaxoSmithKline says.

Here's the company press release announcing the FDA approval. For more information about quitting smoking, check the National Library of Medicine.


Last Updated: